Published • loading... • Updated
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Summary by MarketBeat
4 Articles
4 Articles
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Inovio Pharmaceuticals (NASDAQ:INO) is preparing to launch its first approved product, VOCERYQ, after the Food and Drug Administration granted accelerated approval for the treatment of adults with recurrent respiratory papillomatosis, or RRP, the company said on its third-quarter earnings call. Chi
·Sioux Falls, United States
Read Full Article
Coverage Details
Total News Sources4
Leaning Left1Leaning Right1Center1Last UpdatedBias Distribution34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium
